Correlation Between HyVision System and AptaBio Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HyVision System and AptaBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HyVision System and AptaBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HyVision System and AptaBio Therapeutics, you can compare the effects of market volatilities on HyVision System and AptaBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HyVision System with a short position of AptaBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HyVision System and AptaBio Therapeutics.

Diversification Opportunities for HyVision System and AptaBio Therapeutics

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between HyVision and AptaBio is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding HyVision System and AptaBio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AptaBio Therapeutics and HyVision System is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HyVision System are associated (or correlated) with AptaBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AptaBio Therapeutics has no effect on the direction of HyVision System i.e., HyVision System and AptaBio Therapeutics go up and down completely randomly.

Pair Corralation between HyVision System and AptaBio Therapeutics

Assuming the 90 days trading horizon HyVision System is expected to under-perform the AptaBio Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, HyVision System is 1.47 times less risky than AptaBio Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The AptaBio Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  797,000  in AptaBio Therapeutics on September 2, 2024 and sell it today you would lose (145,000) from holding AptaBio Therapeutics or give up 18.19% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

HyVision System  vs.  AptaBio Therapeutics

 Performance 
       Timeline  
HyVision System 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HyVision System has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
AptaBio Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

HyVision System and AptaBio Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HyVision System and AptaBio Therapeutics

The main advantage of trading using opposite HyVision System and AptaBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HyVision System position performs unexpectedly, AptaBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptaBio Therapeutics will offset losses from the drop in AptaBio Therapeutics' long position.
The idea behind HyVision System and AptaBio Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies